DK116232B - Process for the manufacture of a vaccine with swine fever. - Google Patents

Process for the manufacture of a vaccine with swine fever.

Info

Publication number
DK116232B
DK116232B DK36463A DK36463A DK116232B DK 116232 B DK116232 B DK 116232B DK 36463 A DK36463 A DK 36463A DK 36463 A DK36463 A DK 36463A DK 116232 B DK116232 B DK 116232B
Authority
DK
Denmark
Prior art keywords
vaccine
manufacture
swine fever
swine
fever
Prior art date
Application number
DK36463A
Other languages
Danish (da)
Inventor
J Baker
Original Assignee
Roxane P Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roxane P Inc filed Critical Roxane P Inc
Publication of DK116232B publication Critical patent/DK116232B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK36463A 1962-02-01 1963-01-25 Process for the manufacture of a vaccine with swine fever. DK116232B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17050062A 1962-02-01 1962-02-01

Publications (1)

Publication Number Publication Date
DK116232B true DK116232B (en) 1969-12-22

Family

ID=22620092

Family Applications (1)

Application Number Title Priority Date Filing Date
DK36463A DK116232B (en) 1962-02-01 1963-01-25 Process for the manufacture of a vaccine with swine fever.

Country Status (4)

Country Link
DE (1) DE1492083A1 (en)
DK (1) DK116232B (en)
ES (1) ES284278A1 (en)
GB (1) GB1023526A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
US6291228B1 (en) 1988-08-03 2001-09-18 Vericore Limited Vaccine

Also Published As

Publication number Publication date
DE1492083A1 (en) 1969-08-07
GB1023526A (en) 1966-03-23
ES284278A1 (en) 1963-06-16

Similar Documents

Publication Publication Date Title
DK115403B (en) Process for the preparation of (3-amino-pyrazinoyl) -guanidines.
DK108640C (en) Process for the preparation of a polymide plastic.
DK104675C (en) Process for the preparation of 3-hydroxy-N-nitro-picolinamide.
DK115325B (en) Process for the preparation of phenylalkylsulfamides.
DK111752B (en) Process for the preparation of hexamethylenediamine.
DK116232B (en) Process for the manufacture of a vaccine with swine fever.
DK107092C (en) Process for the preparation of a substituted benzanilide.
DK103476C (en) Process for the preparation of 2-oxa-3-oxo-steroids.
DK109148C (en) Process for the preparation of N-methylglucammonium salicylate.
DK108015C (en) Process for the preparation of a bacterial preparation.
DK111143B (en) Process for the preparation of sulfamylanthranilic acids.
DK109924C (en) Process for the preparation of hydroxybenzaldehydes.
DK103512C (en) Process for the preparation of 3-nitroso-2-oxazolidone.
DK108915C (en) Process for the preparation of 21-acyloxy-acetyloxy-corticosteroids.
DK104063C (en) Process for the preparation of 4-hydroxy-5-halopyrimidines.
DK113647B (en) Process for the preparation of 2-sulfanilamido-5-methoxypyrimidine.
DK115620B (en) Process for the preparation of 17α-chloroethynyl-17β-alkoxysteroids.
DK106337C (en) Process for the preparation of 3α-phenylgranate derivatives.
DK102920C (en) Process for the preparation of 1-cyanolchicine derivatives.
DK119608B (en) Process for the preparation of dibenzocycloheptene derivatives.
DK104680C (en) Process for the preparation of derivatives of 6-methyl-8-aminomethyl-ergoline I.
DK103833C (en) Process for the preparation of desacetylamino-N-methylcolchiceinamide.
DK101983C (en) Process for the preparation of 1-hydroxymethylcolchicine.
DK104621C (en) Process for the preparation of monooxymethylcyclooctane.
DK108027C (en) Process for the preparation of glucuronamides.